?
Peterson Kristine
Director
ImmunoGen, Inc.
US, Waltham [HQ]
CIK
1508596
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
10,000
Price per Share :
$31.23
Equivalence :
$312,300.00
Transaction History
-
M10,000 Shares After TransactionValue : $101,000.00$101,000.00Transaction Date : 11/30/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 11, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
-
M20,000 Shares After TransactionValue : $261,400.00$130,700.00Transaction Date : 11/30/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 11, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
-
S0.0 Shares After TransactionValue : $n/aSold $578,000.00Transaction Date : 11/30/23
-
Footnotes
-
-
Footnotes:#1 Effected pursuant to a trading plan adopted on June 11, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.#2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.